Healthcare -
Biotechnology - NASDAQ - US
$ 18.37
-0.541 %
$ 1.6 B
Market Cap
-4.06
P/E
TVTX - CASH & EQUIVALENTS
Cash & Equivalents TVTX - Travere Therapeutics, Inc.
58.2 M
LAST VALUE
-40.76%
2 YEAR CAGR
-10.77%
5 YEAR CAGR
25.51%
10 YEAR CAGR